Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2022 Tandem Meetings and Transplantation View overview page

2:44
Highlights from the Tandem Meetings: new promising CAR-T constructs
Manali Kamdar • 27 Apr 2022
2:34
Safety & efficacy of iNKTs in dogs
Antonia Rotolo • 6 May 2022
3:29
Next steps in the development of iNKTs for the treatment of hematological malignancies
Antonia Rotolo • 6 May 2022
2:04
Autologous transplantation followed by maintenance vs maintenance alone in patients with MCL
Peter Riedell • 27 Apr 2022
0:52
Can alloHSCT be avoided in Ph+ ALL?
Usman Ali Akbar • 19 Apr 2022
1:29
Restoring the hematolymphoid system in Fanconi anemia
Agnieszka Czechowicz • 25 Apr 2022
2:20
Itacitinib for the prophylaxis of GvHD and CRS in T-cell replete haploidentical PBSCT
John DiPersio • 23 Apr 2022
2:06
Immunogenicity of COVID-19 vaccination in transplant and CAR-T therapy recipients
Muhammad Umair Mushtaq • 25 Apr 2022
2:06
CAR-T therapy vs autologous transplantation in R/R DLBCL
Anna Sureda • 25 Apr 2022
2:16
Cardiac complications after SCT
Christopher Dandoy • 23 Apr 2022
1:20
Repurposing drugs for the treatment of acute GvHD
Shernan Holtan • 25 Apr 2022
2:04
Sleep quality and weight loss in stem cell transplant recipients
Christopher Dandoy • 23 Apr 2022
1:44
Patient-important outcomes in pediatric transplant recipients
Christopher Dandoy • 23 Apr 2022
0:52
Challenges of in vivo gene editing for diseases of the hematopoietic system
Agnieszka Czechowicz • 25 Apr 2022
3:07
Current indications for the use of brentuximab vedotin in Hodgkin lymphoma
Anna Sureda • 25 Apr 2022
1:27
Challenges in CAR-T therapy for myeloid malignancies
Bhagirathbhai Dholaria • 24 Apr 2022
The content of VJHemOnc is intended for healthcare professionals